BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mousa RF, Smesam HN, Qazmooz HA, Al-Hakeim HK, Maes M. A pathway phenotype linking metabolic, immune, oxidative, and opioid pathways with comorbid depression, atherosclerosis, and unstable angina. CNS Spectr 2021;:1-15. [PMID: 34039448 DOI: 10.1017/S1092852921000432] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Al-Hakeim HK, Al-Musawi AF, Al-Mulla A, Al-Dujaili AH, Debnath M, Maes M. The interleukin-6/interleukin-23/T helper 17-axis as a driver of neuro-immune toxicity in the major neurocognitive psychosis or deficit schizophrenia: A precision nomothetic psychiatry analysis. PLoS One 2022;17:e0275839. [PMID: 36256663 DOI: 10.1371/journal.pone.0275839] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Maes M, Al-Rubaye HT, Almulla AF, Al-Hadrawi DS, Stoyanova K, Kubera M, Al-Hakeim HK. Lowered Quality of Life in Long COVID Is Predicted by Affective Symptoms, Chronic Fatigue Syndrome, Inflammation and Neuroimmunotoxic Pathways. Int J Environ Res Public Health 2022;19:10362. [PMID: 36011997 DOI: 10.3390/ijerph191610362] [Reference Citation Analysis]
3 Maes M, Al-rubaye HT, Almulla AF, Al-hadrawi DS, Stoyanova K, Kubera M, Al-hakeim HK. Lowered quality of life in Long COVID is strongly predicted by affective symptoms and chronic fatigue syndrome which are associated with inflammatory processes during the acute infectious phase and consequent neuroimmunotoxic pathways.. [DOI: 10.1101/2022.07.25.22277980] [Reference Citation Analysis]
4 Maes MH, Stoyanov D. False dogmas in mood disorders research: Towards a nomothetic network approach. World J Psychiatry 2022; 12(5): 651-667 [DOI: 10.5498/wjp.v12.i5.651] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
5 Al-musawi AF, Al-hakeim HK, Al-haboby IH, Almulla AF, Maes M. In schizophrenia, the effects of the IL-6/IL-23/Th17 axis on health-related quality of life and disabilities are partly mediated by generalized cognitive decline and the symptomatome.. [DOI: 10.1101/2022.04.30.22274531] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Maes M, Barbosa DS, Almulla AF, Kanchanatawan B. A Novel Pathway Phenotype of Temporal Lobe Epilepsy and Comorbid Psychiatric Disorders: Results of Precision Nomothetic Medicine. Antioxidants 2022;11:803. [DOI: 10.3390/antiox11050803] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
7 Al-hakeim HK, Alhusseini AF, Al-dujaili AH, Debnath M, Maes M. The interleukin-6/interleukin-23/Thelper-17-axis as a driver of neuro-immune toxicity in the major neurocognitive psychosis or deficit schizophrenia: a precision nomothetic psychiatry analysis.. [DOI: 10.1101/2022.02.23.22271393] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Maes M, Barbosa DS, Kanchanatawan B. A novel pathway phenotype of temporal lobe epilepsy and comorbid psychiatric disorders: results of precision nomothetic medicine.. [DOI: 10.1101/2022.02.07.22270647] [Reference Citation Analysis]